← Back to Search

Tibial Nerve Stimulation

eCoin for Urge Urinary Incontinence (RECIPE Trial)

N/A
Recruiting
Research Sponsored by Valencia Technologies Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individual is mentally competent and able to understand all study requirements
Individual has at least one urgency urinary incontinence episode on each of three days as determined on a 3-day voiding diary
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12, 24, 36, 48, and 60 months
Awards & highlights

RECIPE Trial Summary

This trial tests a device to reduce overactive bladder & urgency urinary incontinence episodes in 12 months, using diaries & patient reported-outcomes.

Who is the study for?
This trial is for adults over 18 with urgency urinary incontinence who haven't had success with certain other treatments. Candidates should be able to track their bathroom visits and not be pregnant, have bladder cancer history, or severe conditions like uncontrolled diabetes that could affect the study.Check my eligibility
What is being tested?
The eCoin Tibial Nerve Stimulation device is being tested for safety and effectiveness in treating overactive bladder symptoms. Participants will receive the implant and record their symptoms for a year to see if there's at least a 50% improvement.See study design
What are the potential side effects?
Possible side effects may include discomfort at the implant site, skin irritation or infection, bleeding complications especially if on blood thinners, nerve-related issues in lower extremities, and potential interference with certain medical devices.

RECIPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand all the study requirements and can make decisions.
Select...
I've had sudden urges to urinate that I couldn't control, at least once a day for three days.
Select...
I have been diagnosed with an overactive bladder that causes sudden urges to urinate.

RECIPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12, 24, 36, 48, and 60 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12, 24, 36, 48, and 60 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety
Secondary outcome measures
Responder Rate
Safety Data
Safety data through 7 months post-reimplantation.
Other outcome measures
Device-related adverse events from implantation.
Patient reported overactive bladder condition improvement.
Patient reported qualify of life
+11 more

RECIPE Trial Design

1Treatment groups
Experimental Treatment
Group I: eCoin Tibial Nerve StimulationExperimental Treatment1 Intervention
Subcutaneous stimulation of the tibial nerve using the eCoin device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eCoin Tibial Nerve Stimulation
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Valencia Technologies CorporationLead Sponsor
5 Previous Clinical Trials
252 Total Patients Enrolled

Media Library

eCoin (Tibial Nerve Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05685433 — N/A
Urge Incontinence Research Study Groups: eCoin Tibial Nerve Stimulation
Urge Incontinence Clinical Trial 2023: eCoin Highlights & Side Effects. Trial Name: NCT05685433 — N/A
eCoin (Tibial Nerve Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05685433 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation offer opportunities for individuals to partake?

"As indicated on clinicaltrials.gov, this medical trial is no longer in search of participants. Although the study was first publicized on January 1st 2023 and had its most recent update a month later, 193 other trials are actively recruiting patients at present."

Answered by AI

Who else is applying?

What site did they apply to?
University of California, Irvine
What portion of applicants met pre-screening criteria?
Met criteria
~100 spots leftby Aug 2025